Abnoba Viscum |
Characteristics: |
(i) Favored for an initial high-dose fever-inducing treatment, combining i.v. and s.c. application. |
Application: |
Infusions added to a subcutaneous application: |
(i) Low starting dose between 0.2 and 10 mg (rarely 20–40 mg) or last subcutaneous dose. |
(ii) Stepwise dose increase, depending on the tolerability, up to 20–40 mg or to 160–200 mg as a maintenance dose. |
(iii) Mostly applied weekly. |
For high-dose therapy induction (no prior mistletoe contact): |
(i) Infusions are started on three consecutive days (Fraxini 40–80–160 mg), combined with subcutaneous injection to induce fever |
(e.g., 10 mg day 1 or 3 or else) and, if possible, also intratumoral application. |
(ii) A subcutaneous treatment and weekly or monthly infusions usually follow. |
Helixor |
Characteristics: |
(i) Favored because of its good tolerability. |
(ii) In progressive disease. |
(iii) To support tolerability of chemotherapy. |
(iv) To relieve pain from bone metastases and fatigue. |
Application |
(i) Mali is often used in the host tree, such as in cachectic and metastatic situations. Pini is also used occasionally. |
(ii) Mostly a low starting dose of 100, 200 or 300 mg, stepwise increased up to 600 mg, depending on tolerability. |
(iii) Rarely increased up to 5–7 g. |
(iv) A 5–10 mg initial dose in very sensitive patients, increased up to 50–100 mg. |
Daily application in weak patients and patients at the progressive disease stage, decreased to biweekly application later. |
For pain, 3-4 infusions are given on consecutive days. Three infusions per week are administered for fatigue. |
Iscador |
Characteristics |
(i) Favored for repeated fever induction or temperature response. |
Application |
(i) For fever induction, the dosage has to be high enough and infusion time long enough. For instance: Iscador M or Qu, 5 mg |
(“Spezial”) followed by a stepwise increase to 20–40 mg. |
(ii) Host trees may be combined. |
(iii) Applied once or twice per week initially and eventually every second week. |
(iv) Daily infusions are too strenuous. |